Compliance, Safety & Disclaimers
[DOI] [PubMed] [Google Scholar] [16].Lesnefsky EJ, Gudz TI, Moghaddas S, Migita CT, Ikeda-Saito M, Trukaly PJ, Hoppel CL
While IGF-1 LR3 was engineered for extended half-life and systemic activity, IGF-1 DES follows the opposite strategy: very short half-life (20-30 minutes) but extreme potency at the site of injection
Frequent loose stools and repeated bowel movements can irritate the anal canal and perianal skin
When done under the supervision of a qualified professional, the procedure is generally considered safe
Days 14+: Most patients on weekly protocols report returning to baseline energy by day 10-14, which aligns with the rationale for weekly dosing